Related Experiment Video
Updated: May 5, 2026

In Vitro Selection of Engineered Transcriptional Repressors for Targeted Epigenetic Silencing
Published on: May 5, 2023
LwaCas13a indiscriminately targets the human transcriptome
Aguilar-Martinez E1, Tonthat G1, Antony Adamson1
1Faculty of Biology. Medicine and Health, University of Manchester, Manchester, Greater Manchester, M13 9PT, UK.
Background:
Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-associated protein 13a (Cas13a) has been described as a superior tool to short-interfering RNAs (siRNAs) for specific gene silencing. Cas13 targets RNAs through Watson-Crick binding of the target CRISPR RNA (crRNA) and activation of nuclease activity. In bacteria, once Leptotrichia wadei Cas13a (LwCas13a) has cut its specific target, the trans-collateral activity of the protein degrades any single-stranded RNA present in the cell independent of its sequence or homology to the crRNA. This transcollateral activity has been reported to be absent in mammalian cells. Therefore, in this study, we aimed to downregulate mRNAs expression in mammalian cells (HaCaT and HEK293T) using LwaCas13a.
Methods:
We developed a doxycycline-inducible system to express LwaCas13a in HEK293T cells. The off-target activity of LwaCas13a in HEK293T cells was analyzed using RNA-seq.
Results:
In this study, we observed that activation of LwaCas13a in HEK293T cells led to non-specific targeting of RNAs, which caused cell toxicity and death.
Conclusion:
This study provides evidence of the off-target activity of LwaCas13a in HEK293T cells, making it an unsuitable tool for the specific downregulation of RNAs.
Insights
Leptotrichia wadei Cas13a (LwCas13a) causes cell toxicity and death in mammalian cells due to non-specific RNA targeting. This finding indicates LwCas13a is unsuitable for targeted mRNA downregulation in these systems.
Area of Science:
- Molecular Biology
- Gene Regulation
- RNA Interference
Background:
- CRISPR-Cas13a systems offer RNA-targeting gene silencing.
- Leptotrichia wadei Cas13a (LwCas13a) exhibits RNA degradation in bacteria.
- Trans-collateral RNA degradation by LwCas13a is reportedly absent in mammalian cells.
Purpose of the Study:
- To investigate the efficacy of LwCas13a for mRNA downregulation in mammalian cells.
- To assess the potential off-target effects of LwCas13a in human cell lines.
Main Methods:
- A doxycycline-inducible system was established to express LwCas13a in HEK293T cells.
- RNA sequencing (RNA-seq) was employed to analyze LwCas13a off-target activity.
Main Results:
- LwCas13a activation in HEK293T cells resulted in widespread, non-specific RNA targeting.
- This non-specific activity led to significant cellular toxicity and cell death.
Conclusions:
- LwCas13a exhibits detrimental off-target activity in mammalian cells.
- The observed toxicity renders LwCas13a inappropriate for specific mRNA downregulation applications in human cells.
Related Concept Videos
Non-LTR Retrotransposons
LTR Retrotransposons
The internal coding region of LTR retrotransposons and their mechanism of transposition closely resembles a...
Leaky Scanning
lncRNA - Long Non-coding RNAs
lncRNA - Long Non-coding RNAs

